FDA Brief

Warning letters Food

FDA warning letter to

Knobbe Cattle Company Inc.

High riskIssued May 31, 2023Posted Aug 22, 2023Division of Human and Animal Food Operations West II

Knobbe Cattle Company sold a beef cow for slaughter with an illegal ceftiofur residue and failed to review treatment records.

What happened

FDA inspected Knobbe Cattle Company's West Point, Nebraska, cattle feedlot on March 15 and March 17, 2023. FDA found the firm had sold a beef cow for slaughter on or about September 8, 2022, and USDA/FSIS tissue testing found desfuroylceftiofur, a breakdown product of ceftiofur, in kidney tissue above the 0.4 ppm tolerance. FDA also found the firm failed to review treatment records before shipping the cow and did not follow EXCEDE's labeled withdrawal time.

What FDA found

  1. The company sold a beef cow for slaughter whose kidney tissue contained desfuroylceftiofur, a ceftiofur breakdown product, above the 0.4 ppm tolerance, so the meat was adulterated.

    21 CFR 556.113(b)(1)(i); FD&C Act section 402(a)(2)(C)(ii)
  2. The company held animals under conditions that let a medicated cow be shipped before its withdrawal time because staff did not review treatment records before shipment.

    FD&C Act section 402(a)(4)
  3. The company used EXCEDE (ceftiofur) without following the labeled withdrawal time, and the use was not supervised by a licensed veterinarian.

    21 CFR 530.11(a)
  4. That unsupported use of EXCEDE resulted in an illegal drug residue in the animal.

    21 CFR 530.11(d)
  5. The company caused the new animal drug to be unsafe and adulterated by using it outside its approved labeling.

    FD&C Act section 501(a)(5)

What FDA wants

FDA asks Knobbe Cattle Company to respond in writing within 15 working days with the specific corrective steps taken, an explanation of how recurrence will be prevented, and related documentation; if correction is not complete, the firm must explain the delay and completion timeline.

Who should pay attention

  • cattle feedlots and ranchers shipping animals for slaughter
  • beef processors and meat buyers sourcing from feedlots
  • veterinarians advising livestock producers on drug withdrawal

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Ulrich Farms

    Ulrich Farms sold a cow for slaughter with ampicillin residue above tolerance and kept inadequate treatment records.

    High risk